# Merit Medical to Participate at the J.P. Morgan Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-at-the-j-p-morgan-healthcare-conference-9daaf106
Ticker: MMSI
Company: Merit Medical
Source: Merit Medical
Published: 2025-12-23 14:00 EST
## Summary

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today...

## Article Body
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit Healthcare Conference.

Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, January 13th at 4:30 pm Pacific Time / 7:30 pm Eastern Time.

Presentation materials for the conference will be posted to Merit’s investor relations website, Investor Events and Presentations - Merit Medical . A live audio webcast of the presentation will be accessible under the “Events” section of Merit’s investor relations website at Investor Events and Presentations - Merit Medical . A replay of the presentation will be available on this same website for approximately 90 days.

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.

CONTACTS

PR/Media Inquiries Sarah Comstock

Merit Medical Systems, Inc. +1-801-432-2864 | sarah.comstock@merit.com

Investor Inquiries Mike Piccinino, CFA, IRC Westwicke - ICR +1-443-213-0509 | mike.piccinino@icrhealthcare.com
## Recent Company News
- 2026-07-02 20:05 EST — [Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-second-quarter-2026-results-on-july-30-2026-f3864c0a) — Source: Merit Medical
- 2026-05-19 13:15 EST — [Merit Medical Shareholders Elect Scott R. Ward to Board of Directors](https://biopharmsignal.com/news/MMSI/merit-medical-shareholders-elect-scott-r-ward-to-board-of-directors-b8f2f33a) — Source: Merit Medical
- 2026-05-08 13:25 EST — [Merit Medical to Participate in the Bank of America Healthcare Conference](https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-in-the-bank-of-america-healthcare-conference-20d54d66) — Source: Merit Medical
- 2026-04-30 20:05 EST — [Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance](https://biopharmsignal.com/news/MMSI/merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance-651680cc) — Source: Merit Medical
- 2026-04-02 22:00 EST — [Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026-1af622dd) — Source: Merit Medical
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)